News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Ahrens Brenton Karl
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2022 |
4
| Ahrens Brenton Karl (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 14,838 options to buy
@ $1.59, valued at
$23.6k
|
|
| 09/20/2022 |
4
| Ahrens Brenton Karl (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Sold 15,000 shares
@ $1.9028, valued at
$28.5k
Sold 15,000 shares
@ $1.7652, valued at
$26.5k
Sold 7,246 shares
@ $1.7817, valued at
$12.9k
|
|
| 09/15/2022 |
4
| Ahrens Brenton Karl (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Sold 15,000 shares
@ $2.1412, valued at
$32.1k
Sold 15,000 shares
@ $2.0971, valued at
$31.5k
Sold 15,000 shares
@ $2.0181, valued at
$30.3k
|
|
| 09/12/2022 |
4
| Ahrens Brenton Karl (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Sold 3,298 shares
@ $2.2635, valued at
$7.5k
Sold 15,000 shares
@ $2.3153, valued at
$34.7k
Sold 15,000 shares
@ $2.3072, valued at
$34.6k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2022 |
4
| Ahrens Brenton Karl (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 47,436 options to buy
@ $0.45, valued at
$21.3k
|
|
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2020 |
4
| Ahrens Brenton Karl (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted options to buy
@ $2000000, valued at
$0 |
|
| 06/17/2019 |
4
| Ahrens Brenton Karl (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 19,671 options to buy
@ $6.74, valued at
$132.6k
|
|
| 05/29/2019 |
4
| Ahrens Brenton Karl (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Exercised 6,154 restricted stock units
@ $0 |
|
| 05/30/2018 |
4
| Ahrens Brenton Karl (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Converted 721,408 shares
@ $0
Converted 275,446 shares
@ $0
Converted 229,660 shares
@ $0
Bought 506,656 shares
@ $13, valued at
$6.6M
Converted 721,408 options to buy
@ $0
Converted 275,446 options to buy
@ $0
Converted 229,660 options to buy
@ $0 |
|
| 05/29/2018 |
4
| Ahrens Brenton Karl (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 6,154 restricted stock units
@ $0 |
|
| 05/24/2018 |
3
| Ahrens Brenton Karl (Director) has filed a Form 3 on Iterum Therapeutics plc |
| 07/26/2012 |
4
| Ahrens Brenton Karl (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc. |
| 03/02/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/02/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/24/2011 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|